J&J long-term Tremfya data demonstrates Crohn's remission through three years

Seeking Alpha - Mon, 10/12/2026 - 16:16

Yiren Digital announces update on CEO Ning Tang

Seeking Alpha - Mon, 10/12/2026 - 16:15

St. Joe says all of its commercial properties in northwest Florida are open

Seeking Alpha - Mon, 10/12/2026 - 16:11

Ensign Energy: This Time It's Different For Oilfield Services

Seeking Alpha - Mon, 10/12/2026 - 16:10

Tesla And Wright's Law: My Notes On The Deviations

Seeking Alpha - Mon, 10/12/2026 - 16:07

Semtech retreats 10%, adds to recent retreat amid tech pullback

Seeking Alpha - Mon, 10/12/2026 - 16:05

Ouster: The Eyes Of Physical AI Are Ready To Scale

Seeking Alpha - Mon, 10/12/2026 - 16:03

Bitdeer AI enters into eight-year agreement for A103 data center in Malaysia

Seeking Alpha - Mon, 10/12/2026 - 15:58

Mueller Water names Michael Morgan as CFO

Seeking Alpha - Mon, 10/12/2026 - 15:57

Visa rises for eight straight sessions, hits new all-time high

Seeking Alpha - Mon, 10/12/2026 - 15:53

Applied Materials unveils $5B EPIC center to speed up AI chip R&D

Seeking Alpha - Mon, 10/12/2026 - 15:53

FormFactor and Teradyne collaborate for semiconductor development

Seeking Alpha - Mon, 10/12/2026 - 15:48

Coherent: A Tempting Buy, But There's One Big Reason To Stay Away

Seeking Alpha - Mon, 10/12/2026 - 15:45

Crédit Agricole to acquire IKB Deutsche Industriebank ot expand footprint in Germany

Seeking Alpha - Mon, 10/12/2026 - 15:41

Nu Holdings: Brazil's Election Rally Isn't A Reason To Buy (Downgrade)

Seeking Alpha - Mon, 10/12/2026 - 15:40

Tilray Q1: Not Looking Good, Remains A 'Hold'

Seeking Alpha - Mon, 10/12/2026 - 15:40

Insurance After Purchasing a Used Commercial Truck: What Should Be Checked

TalkMarkets - Mon, 10/12/2026 - 15:39
Insurance After Purchasing a Used Commercial Truck: What Should Be Checked

Stocks making big moves after hours: BMBL, FORM, RDDT

Seeking Alpha - Mon, 10/12/2026 - 15:39

Lumentum Holdings drops 10% as volatile trading continues

Seeking Alpha - Mon, 10/12/2026 - 15:38

Syndax plummets as IPF asset axatilimab fails in phase 2 trial

Seeking Alpha - Mon, 10/12/2026 - 15:38

Pages